The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 780K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for S Crosignani


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
17
Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists.EBI
TBA
57
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids.EBI
TBA
122
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.EBI
Merck Serono
45
Discovery of a novel series of CXCR3 antagonists.EBI
Merck Serono
53
Discovery of a novel series of potent S1P1 agonists.EBI
Merck Serono
33
Discovery of a novel series of selective macrocyclic PKCTheta inhibitors.EBI
Galderma SA
42
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i).EBI
Merck
33
Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.EBI
Iteos Therapeutics
61
Compounds and compositions for inhibiting the activity of SHP2BDB
Novartis
38
Inhibitors of the renal outer medullary potassium channelBDB
Merck Sharp & Dohme
20
S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their useBDB
Merck Sharp & Dohme
3
Evidence of ternary complex formation in Trypanosoma cruzi trans-sialidase catalysis.BDB
Universidade Federal Do Rio De Janeiro
166
PDE 10a inhibitors for the treatment of type II diabetesBDB
Janssen Pharmaceutica
6
Development of hydroxylated naphthylchalcones as polyphenol oxidase inhibitors: Synthesis, biochemistry and molecular docking studies.BDB
University of Technology Sydney
1
[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.BDB
Merck Research Laboratories
50
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.BDB
Merck Research Laboratories